Zobrazeno 1 - 10
of 52
pro vyhledávání: '"J. L. Mcguire"'
Publikováno v:
Lupus. 8:181-187
Objective: To determine if dehydroepiandrosterone (DHEA) is beneficial in severe systemic lupus erythematosus (SLE). Methods: A double-blinded, placebo-controlled, randomized clinical trial in 21 patients with severe and active SLE, manifestated prim
Autor:
N. Nichole Barry, J L McGuire
Publikováno v:
Rheumatic Disease Clinics of North America. 22:531-549
Special considerations need to be given to specific groups of adult athletes. The most common problems and needs of female and older athletes are discussed in the first section of this article. The second section reviews the diagnosis and management
Autor:
N. Nichole Barry, J L McGuire
Publikováno v:
Rheumatic Disease Clinics of North America. 22:515-530
Approximately 50% of all sports participants will be injured at some point, and at least half of these injuries will be attributed to overuse. This article provides an in-depth review of the presentation, diagnosis, and treatment of the most common o
Publikováno v:
Arthritis & Rheumatism. 38:1826-1831
Objective. To determine if dehydroepiandrosterone (DHEA) is beneficial in the treatment of systemic lupus erythematosus (SLE). Methods. In a double-blind, placebo-controlled, randomized trial, 28 female patients with mild to moderate SLE were given D
Publikováno v:
Arthritis & Rheumatism. 37:1305-1310
Objective. To determine if dehydroepiandrosterone (DHEA) has clinical benefits in patients with systemic lupus erythematosus (SLE). Methods. Ten female patients with mild to moderate SLE and various disease manifestations were given DHEA (200 mg/day
Autor:
William M. Ridgway, J L McGuire
Publikováno v:
Hospital Practice. 28:33-40
Recent data indicate that rheumatoid arthritis is more often systemic, progressive, and disabling than benign, and that it reduces life expectancy. The new evidence argues for a dramatic alteration in pharmacologic management. If several months of re
Publikováno v:
Journal of Endocrinology. 131:211-218
Pituitary and ovarian function were studied during the loss and recovery of oestrous cyclical activity in rats following treatment with a sustained release formulation of the gonadotrophin-releasing hormone (GnRH) agonist [imidazole benzyl-d-His6,Pro
Publikováno v:
American Journal of Obstetrics and Gynecology. 163:2127-2131
Biotransformation, pharmacologic, and pharmacokinetic studies of norgestimate and its metabolites indicate that 17-deacetyl norgestimate, along with the parent drug, contributes to the biologic response. The postulated metabolic pathway, which is bas
Publikováno v:
Journal of Antimicrobial Chemotherapy. 25:263-268
The effects of ofloxacin in Salmonella typhimurium infection in mice were compared with those of ciprofloxacin, ampicillin and chloramphenicol. Oral administration of ofloxacin at 10, 50 or 100 mg/kg once per day for seven days significantly (P less